n-hydroxythalidomide has been researched along with 2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione in 1 studies
| Studies (n-hydroxythalidomide) | Trials (n-hydroxythalidomide) | Recent Studies (post-2010) (n-hydroxythalidomide) | Studies (2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione) | Trials (2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione) | Recent Studies (post-2010) (2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 22 | 0 | 10 |
| Protein | Taxonomy | n-hydroxythalidomide (IC50) | 2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione (IC50) |
|---|---|---|---|
| Tubulin alpha-1A chain | Sus scrofa (pig) | 6.9 | |
| Tubulin beta chain | Sus scrofa (pig) | 6.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Katayama, R; Miyachi, H; Naito, M; Noguchi, T | 1 |
1 other study(ies) available for n-hydroxythalidomide and 2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione
| Article | Year |
|---|---|
Cell differentiation inducers derived from thalidomide.
Topics: Antineoplastic Agents; Cell Differentiation; Drug Screening Assays, Antitumor; Flow Cytometry; HL-60 Cells; Humans; Indoles; Isoindoles; Leukemia; Lipopolysaccharide Receptors; Structure-Activity Relationship; Thalidomide | 2005 |